A consensus has been growing about the inequitable readings of pulse oximeters, which measure blood oxygen levels, and the FDA discussed the matter in November 2022. The agency has been working to test the accuracy of pulse oximeters in diverse populations, but the attorneys general letter said pulse oximeters still lack clear warning labels.
The second meeting, marked for Feb. 2, will center on improving study methods that account for patients’ skin pigmentation, race and ethnicity.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
